Oral Small-Molecule GLP-1R Agonist Danuglipron Robustly Reduces Plasma Glucose and Body Weight after Eight Weeks in Japanese Adults with Type 2 Diabetes Mellitus-MedSci.cn

Oral Small-Molecule GLP-1R Agonist Danuglipron Robustly Reduces Plasma Glucose and Body Weight after Eight Weeks in Japanese Adults with Type 2 Diabetes Mellitus

Ono, R; Furihata, K; Ichikawa, Y; Nakazuru, Y; Bergman, A; Gorman, DN; Saxena, AR

DIABETES, 2022; 71 ():

科室
- - 订阅+
  - 更多科室
工具
服务